Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Neurochem. Author manuscript; available in PMC 2013 October 1.
Published in final edited form as:
PMCID: PMC3438380

Comparative protein interactomics of neuroglobin and myoglobin


Neuroglobin is a hypoxia-inducible O2-binding protein with neuroprotective effects in cell and animal models of stroke and Alzheimer’s disease. The mechanism underlying neuroglobin’s cytoprotective action is unknown, although several possibilities have been proposed, including antioxidative and antiapoptotic effects. We used affinity purification-mass spectrometry methods to identify neuroglobin-interacting proteins in normoxic and hypoxic murine neuronal (HN33) cell lysates, and to compare these interactions with those of a structurally and functionally related protein, myoglobin. We report that the protein interactomes of neuroglobin and myoglobin overlap substantially and are modified by hypoxia. In addition, neuroglobin-interacting proteins include partners consistent with both antioxidative and antiapoptotic functions, as well as with a relationship to several neurodegenerative diseases.

Keywords: hypoxia, ischemia, myoglobin, neuroglobin, proteome


Neuroglobin (Ngb) and myoglobin (Mgb) are ancestrally related hemoproteins with a variety of shared features, including ~20% amino acid sequence homology (Burmester et al. 2000). Both occur as monomers, bind O2 with high affinity, scavenge NO, contain hypoxia-inducible mRNA stabilization signals in their 3′-untranslated regions, are expressed preferentially in particular (neuronal and skeletal muscle) tissues, and are cytoprotective (Greenberg et al. 2008; Ordway 2004; Yu et al. 2009). These parallels have led to the suggestion that Ngb and Mgb may have similar functions, including O2 storage or transport and hypoxic adaptation (Brunori and Vallone 2006).

One approach for investigating Ngb function and exploring its relationship to that of Mgb is to examine protein-protein interactions (Droit et al. 2005). A small number of studies to date have reported interactions between Ngb and other proteins. Yeast two-hybrid screens were used to demonstrate as interactors the Na/K ATPase β1, β2 and β3 subunits; flotillin-1; cytochrome c1; ubiquitin C; disheveled homolog 1; synaptotagmin I; electron transferring flavoprotein α subunit; GABAA receptor-associated protein-like 1; microtubule-associated protein 1A; and voltage-dependent anion channel 1 ( Wakasugi et al. 2004a; Xu et al. 2003; Yu et al. 2012). Surface plasmon resonance identified the guanine nucleotide-binding protein Gαi subunit (Wakasugi et al. 2003), cystatin C (Wakasugi et al. 2004b), and prion protein (Palladino et al. 2011). Co-immunoprecipitation showed interaction between Ngb and 14-3-3 (Jayaraman et al. 2011). Finally, redox reactions with Ngb have been documented for cytochromes b5 and c (Fago et al. 2006) and thioredoxin reductase (Trandafir et al. 2007). Of these Ngb-interacting proteins, only cytochromes b5 (Liang et al. 2002) and c (Wu et al. 1972) have also been shown to interact with Mgb.

To further investigate Ngb protein-protein interactions and compare them to interactions with Mgb, we incubated HN33 (mouse hippocampal neuron × N18TG2 neuroblastoma) cell lysates with recombinant mouse Ngb or horse Mgb, isolated Ngb- or Mgb-immunoreactive complexes, and analyzed the Ngb and Mgb interactomes using affinity purification-mass spectrometry.



Dulbecco’s modified Eagles’s medium (DMEM) with L-glutamine, phosphate buffered saline (PBS), culture dishes, protease inhibitor, cobalt purification columns, biotin buffer, biotin labeling kit, monomeric streptavidin columns, Zeba spin columns, biotin quantification assay, dialysis cassette, and protein concentrator were purchased from Thermo Scientific (Rockford, IL). Fetal bovine serum (FBS), SDS (sodium doceyl sulfate)-PAGE (polyacrylamide gel electrophoresis) gels, dithiothreitol (DTT), pET expression vector, BL21 competent cells, SDS western blot loading buffer, 0.05% Trypsin-EDTA, penicillin, and streptomycin were purchased from Invitrogen (Carlsbad, CA). Horse heart myoglobin, luria broth (LB), imidazole, acetonitrile, ammonium bicarbonate, formic acid, and isopropyl-β-D-thiogalactopyranoside (IPTG) were purchased from Sigma (St. Louis, MO). Trypsin was purchased from Promega (Madison, WI).

Cell culture

HN33 cells, provided originaly by Dr. Bruce H. Wainer, were plated at 80% confluency on 100-mm culture dishes and maintained at 37°C in humidified 5% CO2/95% air, in DMEM supplemented with heat-inactivated FBS (10%) and 50 U/mL penicillin/streptomycin, as described previously (Haines et al, 2012). For hypoxia treatment, cells were placed in a chamber flushed with 95% N2/5% CO2 for 16 h at 37°C.

Recombinant protein expression

Full-length mouse Ngb cDNA was cloned into a pET protein expression vector and transformed into BL21 cells. Fresh LB medium was inoculated with a starter culture grown the day before. Around OD 0.4-0.6, protein expression was induced with 1 mM IPTG. After 6 h of expression, bacteria were pelleted, frozen at −80°C, reconstituted with buffer containing 20 mM Tris/10 mM NaCl, sonicated for 30 sec, and cleared by centrifugation at 1000 × g for 5 min. Lysates were incubated with cobalt spin columns overnight on a rocker at 4°C. Protein was washed and later eluted using increasing concentrations of imidazole. Recombinant Ngb was then dialyzed in PBS overnight.

Protein preparation, binding and pulldown

Recombinant mouse Ngb and horse heart Mgb were biotin-labeled using an EZ-Link Sulfo-NHS-Biotinylation Kit (Thermo Scientific) and the remaining free biotin was removed using a Zeba spin column. Biotin labeling was confirmed using a fluorescent biotin quantification kit (Thermo Scientific). Protein concentration was determined by the BCA protein assay (Biorad, Hercules, CA).

Sixteen 100-mm dishes of HN33 cells were scraped and pelleted for each (hypoxia or normoxia) condition. Cells were lysed with radioimmunoprecipitation assay buffer and protease inhibitors and rocked at 4°C for 2 h; lysates were cleared by centrifugation at 1000 × g for 5 min and later dialyzed in PBS with protease inhibitors.

Biotin-labeled Ngb or Mgb (1 mg) was incubated with 8 mg of total protein from hypoxic or normoxic cell lysates for 2 h at 37°C. The combined protein mixtures were passed over a reversibly bindable monomeric streptavidin column (Thermo Scientific), washed with PBS to remove unbound protein, and eluted with 2 mM biotin in 2-ml fractions. Samples were measured at 280 nm using a Nano-drop spectrophotometer (Thermo Scientific) to determine the fractions that contained the eluted protein, and fractions containing protein were pulled and concentrated to <250 μL. For each condition, 200 μg of protein was denatured with SDS and DTT, incubated at 70°C for 10 min, loaded into 4 separate wells of a 12% SDS-PAGE gel, and run at 200 V for 25 min. A separate gel and running buffer was used for each condition. The gel was incubated with SYPRO Ruby stain (Life Technologies, Grand Island, NY) and illuminated with UV light, and 12 sections were cut out corresponding to size.

In-gel protein digestion

Protein digestion, liquid chromatography (LC)/ mass spectroscopy (MS), and database searching were performed by the Keck Biotechnology Resource at Yale University (New Haven, CT). Additional data analysis was provided by the Buck Institute’s Bioinformatics Core. Proteins isolated in SDS-PAGE gels were subjected to in situ enzymatic digestion. Gel slices were washed with 250 μl of 50% acetonitrile/50% water for 5 min followed by 250 μl of 50 mM ammonium bicarbonate in 50% acetonitrile/50% water for 30 min. A final wash was done using 10 mM ammonium bicarbonate in 50% acetonitrile/50% water for 30 minutes. After washing, gels were dried in a Speedvac and rehydrated with 0.1 μg of modified trypsin per ~15 mm3 of gel in 15 μl of 10 mM ammonium bicarbonate. Samples were digested at 37°C for 16 h.


LC-MS/MS was performed using an LTQ Orbitrap (Thermo Scientific) equipped with a Waters nanoAcquity UPLC system (Waters, Milford, MA), Waters Symmetry® C18 180 μm x 20 mm trap column, and a 1.7-μm, 75 μm x 250 mm nanoAcquity™ UPLC™ column (35°C) for peptide separation. Trapping was done at 15 μl/min, in 99% Buffer A (100% water/0.1% formic acid) for 1 min. Peptide separation was performed at 300 nL/min with Buffer A and Buffer B (100% acetonitrile/0.075% formic acid). A linear gradient (51 min) was run with 5% buffer B under initial conditions, 50% buffer B at 50 min, and 85% buffer B at 51 min. MS was acquired in the Orbitrap using 1 microscan, and a maximum inject time of 900, followed by four data-dependent MS/MS acquisitions in the ion trap. For phosphopeptide analysis, Neutral loss scans (MS3) were also obtained for 98.0, 49.0, and 32.7 atomic mass units.

Database searching

MS/MS spectra were searched using the Mascot algorithm (version 2.2.0) for uninterpreted MS/MS spectra, after using the Mascot Distiller program to generate Mascot-compatible files. The Mascot Distiller program combines sequential MS/MS scans from profile data that have the same precursor ion; charge states of +2 and +3 are located preferentially with a signal:noise ratio of ≥1.2 and a peak list is generated for database searching. A protein was considered to have been identified when Mascot listed it as significant and when more than two peptides matched the same protein. The NCBI non-redundant (NR) database was used. The Mascot significance score match is based on a MOWSE score and relies on multiple matches to more than one peptide from the same protein. Typical parameters used for searching are partial methionine oxidation and propionamide (cysteine modification), a peptide tolerance of +20 ppm, MS/MS fragment tolerance of +0.6 Da, and peptide charges of +2 or +3. Normal and decoy database searches are run.

Proteins identified with an expectation score of >0.01 were excluded. Proteins listed in the common Repository of Adventitious Proteins (cRAP, were excluded with two exceptions—Cyc and Thio—which were previously reported Ngb interactors and did not appear in all four data sets (Ngb/normoxia, Ngb/hypoxia, Mgb /normoxia, Mgb/hypoxia).


A total of 331 proteins were identified as interactors with Ngb or Mgb based on the presence of more than one peptide fragment (Figure 1). Of these, 216 (65%) interacted with Ngb, 299 (90%) with Mgb, and 184 (56%) with both; 277 interactors (84%) were detected under normoxic and 248 (75%) under hypoxic conditions. Viewed alternatively, of 277 proteins identified in normoxic cells, 3% interacted only with Ngb, 32% only with Mgb, and 65% with both; of 248 proteins detected in hypoxic cells, 10% were exclusively Ngb interactors, 20% were exclusively Mgb interactors, and the remaining 70% interacted with both (Figure 2).

Figure 1
Protein interactors with Ngb under normoxic (NN) and hypoxic (NH) and with Mgb under normoxic (MN) and hypoxic (MH) conditions.
Figure 2
Numbers of protein interactions with Ngb and with Mgb under normoxic and hypoxic conditions, indicating the extent of overlap between Ngb and Mgb interactomes and the effect of hypoxia.

Among Ngb-interacting proteins, we were interested to observe whether our sample included previously reported interactors or related proteins. Ngb has guanine nucleotide dissociation inhibitor (GDI) activity (Wakasugi et al. 2003), and proteins associated with Ngb under normoxic conditions included two GDIs: Rho GDIα (Gdir1) and translationally controlled tumor protein (Tctp). Ngb is a redox partner of cytochrome c (Fago et al. 2006), and both cytochrome c (Cyc) and cytochrome c2 (Cyc2), which shares 86% amino acid homology with Cyc, associated with Ngb under hypoxic conditions. Ngb is reduced by thioredoxin reductase (Trandafir et al. 2007), and interacted with thioredoxin reductase (Thio) under hypoxic and with thioredoxin-like protein 1 (Txnl1) under both normoxic and hypoxic conditions. Ngb co-immunoprecipitates with 14-3-3 (Jayaraman et al. 2011), and several 14-3-3 isoforms were detected as Ngb interactors in normoxic and hypoxic cells.

Because Ngb levels are increased by hypoxia (Sun et al. 2001) via hypoxia-inducible factor-1 (Hif1) (Haines et al. 2012), we looked for other hypoxia-inducible proteins among the interactors we identiifed. Examples found included the Hif1 transcriptional targets, enolase 1 (Enoa) and lactate dehydrogenase A (Ldha) (Semenza et al. 1996), under hypoxic and both normoxic and hypoxic conditions, respectively. Another interactor was prefoldin subunit 3 (Pfd3), a protein that binds to von Hippel-Lindau (Vhl), which promotes the proteasomal degradation of the Ngb inducer, Hif1 (Maxwell et al. 1999).

The neuroprotective effects of Ngb have been attributed in some reports to antiapoptotic effects mediated through binding to cytochrome c (Cyc) or apoptosis inducing factor (Aif) (Fago et al. 2006). Cyc, Cyc2, and Aif (Aifm) were all identified as Ngb interactors under hypoxic conditions.

Another hypothesis regarding the mechanism of Ngb’s cytoprotective action involves attenuation of oxidative injury, based on the ability of Ngb to protect against injury induced by, e.g., H2O2 (Fordel et al. 2006; Li et al. 2008) or NO (Brunori et al. 2005; Jin et al. 2008). Ngb interacted with the antioxidant enzyme Thio in hypoxic cells and with the mitochondrial antioxidant thioredoxin-dependent peroxide reductases (peroxiredoxins), Prdx3, Prdx4 and Prdx6, in normoxic or both normoxic and hypoxic cells.

Although the neuroprotective action of Ngb was identified first in relation to hypoxic and ischemic injury (Sun et al. 2001; 2003), subsequent investigations have pointed to a possible connection with Alzheimer’s disease (Chen et al. 2012; Khan et al. 2007; Li et al. 2008). In this regard, thimet oligopeptidase (Thop1), a protein with Alzheimer precursor protein β-secretase activity (Papastoitsis et al. 1994), was a Ngb interactor in hypoxic cells. Additional neurological disease-related proteins found to interact with Ngb included the zinc-finger protein Zpr1, which has been proposed as a modifier of disease severity in spinal muscular atrophy (Ahmad et al. 2012); DJ-1 (Park7), which is associated with autosomal recessive familial Parkinson’s disease, and ubiquitin carboxyl-terminal esterase L1 (Uchl1), which may modify disease risk (Lee and Liu 2008); and fused in sarcoma (Fus), mutations in which have been implicated in behavioral variant frontotemporal dementia and motor neuron disease (Mackenzie and Neumann 2011).

As noted, there was substantial overlap between Ngb- and Mgb-interacting proteins: 65% in normoxic and 70% in hypoxic cells. Cytochrome c, one protein with which both Ngb and Mgb have been reported to interact (Wu et al. 1972;Fago et al. 2006) and with which Ngb interacted in this study, was not found among Mgb interactors. Proteins mentioned above for Ngb, with which Mgb also interacted, included 14-3-3 isoforms, Aifm, Enoa, Fus, Ldha, Park7, Pfd3, Prdx6, Thio, Txnl1, and Uchl1.

One small but potentially interesting group of proteins consists of those that interact with both Ngb and Mgb, but only under hypoxic conditions. These included brain acid-soluble protein 1 (also known as brain-abundant membrane-attached signal protein 1; Basp1), insulin-degrading enzyme (Ide), prolyl endopeptidase (Prep), selenocysteine insertion sequence (SECIS)-binding protein 2 (Sbp2), and vacuolar proton pump subunit F (Vatf). Basp1 is involved in the formation of membrane lipid microdomains (rafts) (Epand et al. 2005), to which the Ngb interactor flotillin-1 is localized (Wakasugi et al. 2004a), and which is inhibited in hypoxic neurons by Ngb overexpression (Khan et al. 2008). Ide contributes to clearance of β-amyloid and reduced Ide activity has been linked to some pedigrees with familial Alzheimer’s disease (Kim et al. 2007). Prep expression is altered in hippocampus of Alzheimer’s disease transgenic mice (Rossner et al. 2005). Sbp2 is involved in protection from oxidative injury, and Sbp2 knockdown triggers caspase- and cytochrome c-dependent apoptosis (Papp et al. 2010). Vatf is part of a protein complex that helps to regulate Hif1 levels by competing with Vhl (Lim et al. 2007).


The main finding of this study is that Ngb interacts with numerous proteins, including proteins related to known aspects of Ngb function, as well as proteins with which Mgb also interacts. Two key properties of Ngb—hypoxic induction and neuroprotection—were particularly reflected in the observed interactome. Thus, Ngb interactors included other hypoxia- and Hif1-inducible proteins, namely Enoa and Ldha, as well as Pfd3, a protein involved in regulating Hif1 levels. The neuroprotective effects of Ngb have been attributed variously to antioxidative effects (Fordel et al. 2006), antiapoptotic effects (Fago et al. 2006), and inhibition of guanine nucleotide dissociation from G proteins (Wakasugi et al. 2003). Accordingly, Ngb interactors found in this study included antioxidative proteins (Prdx3, Prdx4, Prdx6), proapoptotic proteins (Cycs, Cyc2, Aifm), and GDI inhibitors (Gdir1, Tctp). Ngb attenuates brain injury in animal models of acute (stroke) and chronic (Alzheimer’s disease) neurodegeneration, and several interactors implicated in neurodegenerative disorders (Fus, Park7, Thop1, Uchl1, Zpr1) were also identified. Finally, two interactors demonstrated in previous studies, Cycs and 14-3-3 isoforms, were recognized in this study as well.

Mgb shared 65% of Ngb interactors under normoxic and 70% under hypoxic conditions, indicating substantial overlap. Although Mgb is normally found primarily in skeletal muscle and Ngb in neurons, they are related in structure (Burmester et al. 2000) and perhaps also in function (Brunori and Vallone 2006). Thus, Mgb interacted with some of the same hypoxia-inducible (Enoa, Ldha), antioxidative (Prdx6), proapoptotic (Aifm), and disease-related (Fus, Park7, Uchl1) proteins observed for Ngb. Mgb is not normally expressed in neurons, but the sharing of interactors with Ngb may argue that it has functions in muscle analogous to those of Ngb in neurons.

A small group of novel interactors—Basp1, Ide, Prep, Sbp2, Vatf—were distinguished by associating with both Ngb and Mgb exclusively under hypoxic conditions. These interactions could contribute to cytoprotection against hypoxia. For example, sequestration by Ngb of proteins that participate in the formation of (Basp1) or localize to (flotillin-1) lipid rafts, which have been implicated in hypoxic cell death (Khan et al. 2008), could confer protection by inhibiting raft formation. Conversely, Ngb could activate or otherwise promote the effects of interactors with cytoprotective effects, such as the antioxidative and antiapoptotic protein Sbp2 or the Hif1-stabilizing protein Vatf.

The results of protein-interaction studies should be interpreted with circumspection, due to limitations in their completeness, sensitivity, and precision (Vidal et al. 2011). For example, conditions under which these studies are conducted do not necessarily reflect the protein concentrations or compartmentalization that occurs in vivo (Sardiu and Washburn 2011). Indirect interactions, such as between non-interacting members of interacting protein complexes, may be detected, whereas genuine but low-affinity interactions or interactions involving low-abundance proteins may be missed. In comparing Ngb and Mgb interactomes in the present study in particular, additional potential confounds are that Mgb is not normally expressed in neuronal cells, and that homology between horse Mgb (which we used) and mouse Mgb (with which mouse proteins would normally interact) is incomplete (82%). Nevertheless, studies of protein-protein interactions may have value for illuminating mechanisms involved in the cytoprotective effects of proteins like Ngb.

Supplementary Material

Supp Table S1


Supported by NIH grants R01 NS62040 and U54 HG04028 and CIRM grant TG2-01155. The authors have no conflicts of interest to declare.


Dulbecco’s modified Eagles’s medium
phosphate buffered saline
fetal bovine serum
sodium dodecyl sulfate
polyacrylamide gel electrophoresis
luria broth
liquid chromatography
mass spectroscopy
guanine nucleotide dissociation inhibitor


SUPPORTING INFORMATION Additional supporting information may be found in the online version of this article: Table S1. Protein codes for Ngb and Mgb interactomics.


  • Ahmad S, Wang Y, Shaik GM, Burghes AH, Gangwani L. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Hum. Mol. Genet. 2012 e-pub ahead of print 14 March 2012: doi 10.1093/hmg/dds102. [PMC free article] [PubMed]
  • Brunori M, Giuffre A, Nienhaus K, Nienhaus GU, Scandurra FM, Vallone B. Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes. Proc. Natl. Acad. Sci. USA. 2005;102:8483–8488. [PubMed]
  • Brunori M, Vallone B. A globin for the brain. FASEB J. 2006;20:2192–2197. [PubMed]
  • Burmester T, Weich B, Reinhardt S, Hankeln T. A vertebrate globin expressed in the brain. Nature. 2000;407:520–523. [PubMed]
  • Chen LM, Xiong YS, Kong FL, Qu M, Wang Q, Chen XQ, Wang JZ, Zhu LQ. Neuroglobin attenuates Alzheimer-like tau hyperphosphorylation by activating Akt signaling. J. Neurochem. 2012;120:157–164. [PubMed]
  • Droit A, Poirier GG, Hunter JM. Experimental and bioinformatic approaches for interrogating protein-protein interactions to determine protein function. J. Mol. Endocrinol. 2005;34:263–280. [PubMed]
  • Epand RF, Sayer BG, Epand RM. Induction of raft-like domains by a myristoylated NAP-22 peptide and its Tyr mutant. FEBS J. 2005;272:1792–1803. [PubMed]
  • Fago A, Mathews AJ, Moens L, Dewilde S, Brittain T. The reaction of neuroglobin with potential redox protein partners cytochrome b5 and cytochrome c. FEBS Lett. 2006;580:4884–4888. [PubMed]
  • Fordel E, Thijs L, Martinet W, Lenjou M, Laufs T, Van Bockstaele D, Moens L, Dewilde S. Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci. Lett. 2006;410:146–151. [PubMed]
  • Greenberg DA, Jin K, Khan A. Neuroglobin: an endogenous neuroprotectant. Curr. Opin. Pharmacol. 2008;8:20–24. [PMC free article] [PubMed]
  • Haines B, Demaria M, Mao X, Xie L, Campisi J, Jin K, Greenberg DA. Hypoxia-inducible factor-1 and neuroglobin expression. Neurosci. Lett. 2012;514:137–140. [PMC free article] [PubMed]
  • Jayaraman T, Tejero J, Chen BB, Blood AB, Frizzell S, Shapiro C, Tiso M, Hood BL, Wang X, Zhao X, Conrads TP, Mallampalli RK, Gladwin MT. 14-3-3 binding and phosphorylation of neuroglobin during hypoxia modulate six-to-five heme pocket coordination and rate of nitrite reduction to nitric oxide. J. Biol. Chem. 2011;286:42679–42689. [PMC free article] [PubMed]
  • Jin K, Mao XO, Xie L, Khan AA, Greenberg DA. Neuroglobin protects against nitric oxide toxicity. Neurosci. Lett. 2008;430:135–137. [PMC free article] [PubMed]
  • Khan AA, Mao XO, Banwait S, Jin K, Greenberg DA. Neuroglobin attenuates β-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc. Natl. Acad. Sci. USA. 2007;104:19114–19119. [PubMed]
  • Khan AA, Mao XO, Banwait S, Dermardirossian CM, Bokoch GM, Jin K, Greenberg DA. Regulation of hypoxic neuronal death signaling by neuroglobin. FASEB J. 2008;22:1737–1747. [PMC free article] [PubMed]
  • Kim M, Hersh LB, Leissring MA, Ingelsson M, Matsui T, Farris W, Lu A, Hyman BT, Selkoe DJ, Bertram L, Tanzi RE. Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. J. Biol. Chem. 2007;282:7825–7832. [PubMed]
  • Lee FJ, Liu F. Genetic factors involved in the pathogenesis of Parkinson’s disease. Brain Res. Rev. 2008;58:354–364. [PubMed]
  • Li RC, Morris MW, Lee SK, Pouranfar F, Wang Y, Gozal D. Neuroglobin protects PC12 cells against oxidative stress. Brain Res. 2008;1190:159–166. [PMC free article] [PubMed]
  • Liang ZX, Jiang M, Ning Q, Hoffman BM. Dynamic docking and electron transfer between myoglobin and cytochrome b5. J. Biol. Inorg. Chem. 2002;7:580–588. [PubMed]
  • Lim JH, Park JW, Kim SJ, Kim MS, Park SK, Johnson RS, Chun YS. ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1α (HIF-1α) binding and mediates HIF-1α expression by bafilomycin A1. Mol. Pharmacol. 2007;71:942–948. [PubMed]
  • Mackenzie IR, Neumann M. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Brain Res. 2011 e-pub ahead of print 13 December 2011: doi:10.1016/j.brainres.2011.12.010. [PubMed]
  • Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271–275. [PubMed]
  • Ordway GA. Myoglobin: an essential hemoprotein in striated muscle. J. Exp. Biol. 2004;207:3441–3446. [PubMed]
  • Palladino P, Scaglione GL, Arcovito A, Maria Vitale R, Amodeo P, Vallone B, Brunori M, Benedetti E, Rossi F. Neuroglobin-prion protein interaction: what’s the function? J. Pept. Sci. 2011;17:387–391. [PubMed]
  • Papastoitsis G, Siman R, Scott R, Abraham CR. Identification of a metalloprotease from Alzheimer’s disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments. Biochemistry. 1994;33:192–199. [PubMed]
  • Papp LV, Lu J, Bolderson E, Boucher D, Singh R, Holmgren A, Khanna KK. SECIS-binding protein 2 promotes cell survival by protecting against oxidative stress. Antioxid. Redox Signal. 2010;12:797–808. [PubMed]
  • Rossner S, Schulz I, Zeitschel U, Schliebs R, Bigl V, Demuth HU. Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer’s disease. Neurochem. Res. 2005;30:695–702. [PubMed]
  • Sardiu ME, Washburn MP. Building protein-protein interaction networks with proteomics and informatics tools. J. Biol. Chem. 2011;286:23645–23651. [PMC free article] [PubMed]
  • Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 1996;271:32529–32537. [PubMed]
  • Sun Y, Jin K, Mao XO, Zhu Y, Greenberg DA. Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury. Proc. Natl. Acad. Sci. USA. 2001;98:15306–15311. [PubMed]
  • Sun Y, Jin K, Peel A, Mao XO, Xie L, Greenberg DA. Neuroglobin protects the brain from experimental stroke in vivo. Proc. Natl. Acad. Sci. USA. 2003;100:3497–3500. [PubMed]
  • Trandafir F, Hoogewijs D, Altieri F, Rivetti di Val Cervo P, Ramser K, Van Doorslaer S, Vanfleteren JR, Moens L, Dewilde S. Neuroglobin and cytoglobin as potential enzyme or substrate. Gene. 2007;398:103–113. [PubMed]
  • Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell. 2011;144:986–998. [PMC free article] [PubMed]
  • Wakasugi K, Nakano T, Morishima I. Oxidized human neuroglobin acts as a heterotrimeric Gα protein guanine nucleotide dissociation inhibitor. J. Biol. Chem. 2003;278:36505–36512. [PubMed]
  • Wakasugi K, Nakano T, Kitatsuji C, Morishima I. Human neuroglobin interacts with flotillin-1, a lipid raft microdomain-associated protein. Biochem. Biophys. Res. Commun. 2004a;318:453–460. [PubMed]
  • Wakasugi K, Nakano T, Morishima I. Association of human neuroglobin with cystatin C, a cysteine proteinase inhibitor. Biochemistry. 2004b;43:5119–5125. [PubMed]
  • Wu CS, Duffy P, Brown WD. Interaction of myoglobin and cytochrome c. J. Biol. Chem. 1972;247:1899–1903. [PubMed]
  • Xu WL, Wang CL, Liao ZY, Zhang YL, Yu LH, Meng FW, Wang XX, Meng FW, Yin ZY, Qian LJ, Zhang CG. Identification of interaction and interaction domains between neuroglobin and Na+, K+-ATPase beta2 subunit. Acta Biochim. Biophys. Sinica. 2003;35:823–828. [PubMed]
  • Yu Z, Fan X, Lo EH, Wang X. Neuroprotective roles and mechanisms of neuroglobin. Neurol. Res. 2009;31:122–127. [PMC free article] [PubMed]
  • Yu Z, Liu N, Wang Y, Li X, Wang X. Identification of neuroglobin-interacting proteins using yeast two-hybrid screening. Neuroscience. 2012;200:99–105. [PMC free article] [PubMed]